720 related articles for article (PubMed ID: 27061322)
61. Metabolomics as a tool for drug discovery and personalised medicine. A review.
Mastrangelo A; Armitage EG; García A; Barbas C
Curr Top Med Chem; 2014; 14(23):2627-36. PubMed ID: 25515755
[TBL] [Abstract][Full Text] [Related]
62. Correlating and Combining Genomic and Proteomic Assessment with In Vivo Molecular Functional Imaging: Will This Be the Future Roadmap for Personalized Cancer Management?
Basu B; Basu S
Cancer Biother Radiopharm; 2016 Apr; 31(3):75-84. PubMed ID: 27093341
[TBL] [Abstract][Full Text] [Related]
63. Analysis of metabolomic data: tools, current strategies and future challenges for omics data integration.
Cambiaghi A; Ferrario M; Masseroli M
Brief Bioinform; 2017 May; 18(3):498-510. PubMed ID: 27075479
[TBL] [Abstract][Full Text] [Related]
64. Challenges in Metabolomics-Based Tests, Biomarkers Revealed by Metabolomic Analysis, and the Promise of the Application of Metabolomics in Precision Medicine.
Di Minno A; Gelzo M; Caterino M; Costanzo M; Ruoppolo M; Castaldo G
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563604
[TBL] [Abstract][Full Text] [Related]
65. Cardiovascular proteomics: tools to develop novel biomarkers and potential applications.
Arab S; Gramolini AO; Ping P; Kislinger T; Stanley B; van Eyk J; Ouzounian M; MacLennan DH; Emili A; Liu PP
J Am Coll Cardiol; 2006 Nov; 48(9):1733-41. PubMed ID: 17084242
[TBL] [Abstract][Full Text] [Related]
66. What did we learn from multiple omics studies in asthma?
Ivanova O; Richards LB; Vijverberg SJ; Neerincx AH; Sinha A; Sterk PJ; Maitland-van der Zee AH
Allergy; 2019 Nov; 74(11):2129-2145. PubMed ID: 31004501
[TBL] [Abstract][Full Text] [Related]
67. Personalized medicine using omics approaches in acute respiratory distress syndrome to identify biological phenotypes.
Battaglini D; Al-Husinat L; Normando AG; Leme AP; Franchini K; Morales M; Pelosi P; Rocco PR
Respir Res; 2022 Nov; 23(1):318. PubMed ID: 36403043
[TBL] [Abstract][Full Text] [Related]
68. Second Era of OMICS in Caries Research: Moving Past the Phase of Disillusionment.
Nascimento MM; Zaura E; Mira A; Takahashi N; Ten Cate JM
J Dent Res; 2017 Jul; 96(7):733-740. PubMed ID: 28384412
[TBL] [Abstract][Full Text] [Related]
69. [Gastroenterological Cancer Diagnosis by Metabolomics-Discovery of Pancreatic Cancer Biomarker].
Yoshida M; Nishiumi S; Azuma T
Rinsho Byori; 2015 Apr; 63(4):450-6. PubMed ID: 26536778
[TBL] [Abstract][Full Text] [Related]
70. Cancer biomarker discovery: Opportunities and pitfalls in analytical methods.
Issaq HJ; Waybright TJ; Veenstra TD
Electrophoresis; 2011 Apr; 32(9):967-75. PubMed ID: 21449066
[TBL] [Abstract][Full Text] [Related]
71. Human metabolomics: strategies to understand biology.
Ramautar R; Berger R; van der Greef J; Hankemeier T
Curr Opin Chem Biol; 2013 Oct; 17(5):841-6. PubMed ID: 23849548
[TBL] [Abstract][Full Text] [Related]
72. New opportunities from the cancer metabolome.
Aboud OA; Weiss RH
Clin Chem; 2013 Jan; 59(1):138-46. PubMed ID: 23150057
[TBL] [Abstract][Full Text] [Related]
73. Metabolomic and glycomic findings in posttraumatic stress disorder.
Konjevod M; Tudor L; Svob Strac D; Nedic Erjavec G; Barbas C; Zarkovic N; Nikolac Perkovic M; Uzun S; Kozumplik O; Lauc G; Pivac N
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jan; 88():181-193. PubMed ID: 30025792
[TBL] [Abstract][Full Text] [Related]
74. "Omics" of High Altitude Biology: A Urinary Metabolomics Biomarker Study of Rats Under Hypobaric Hypoxia.
Koundal S; Gandhi S; Kaur T; Mazumder A; Khushu S
OMICS; 2015 Dec; 19(12):757-65. PubMed ID: 26669710
[TBL] [Abstract][Full Text] [Related]
75. Clinical proteomics-driven precision medicine for targeted cancer therapy: current overview and future perspectives.
Zhou L; Wang K; Li Q; Nice EC; Zhang H; Huang C
Expert Rev Proteomics; 2016; 13(4):367-81. PubMed ID: 26923776
[TBL] [Abstract][Full Text] [Related]
76. Omics sciences and precision medicine in Urothelial Carcinoma.
Medori MC; Micheletti C; Madeo G; Maltese PE; Tanzi B; Tezzele S; Mareso C; Generali D; Donofrio CA; Donofrio CA; Cominetti M; Fioravanti A; Riccio L; Beccari T; Ceccarini MR; Stuppia L; Stuppia L; Gatta V; Cristoni S; Ahmed R; Ahmed R; Cecchin S; Marceddu G; Bertelli M
Clin Ter; 2023; 174(Suppl 2(6)):1-10. PubMed ID: 37994743
[TBL] [Abstract][Full Text] [Related]
77. [Omics biomarkers and early diagnostics].
Moshkovskii SA
Biomed Khim; 2017 Oct; 63(5):369-372. PubMed ID: 29080866
[TBL] [Abstract][Full Text] [Related]
78. Omics Data and Their Integrative Analysis to Support Stratified Medicine in Neurodegenerative Diseases.
La Cognata V; Morello G; Cavallaro S
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34062930
[TBL] [Abstract][Full Text] [Related]
79. Proteomics and Metabolomics Approaches towards a Functional Insight onto AUTISM Spectrum Disorders: Phenotype Stratification and Biomarker Discovery.
Ristori MV; Mortera SL; Marzano V; Guerrera S; Vernocchi P; Ianiro G; Gardini S; Torre G; Valeri G; Vicari S; Gasbarrini A; Putignani L
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872562
[TBL] [Abstract][Full Text] [Related]
80. Gender-related metabolomics and lipidomics: From experimental animal models to clinical evidence.
Audano M; Maldini M; De Fabiani E; Mitro N; Caruso D
J Proteomics; 2018 Apr; 178():82-91. PubMed ID: 29122727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
